Trial intelligence / Profile preview

Effect of pioglitazone on portal and systemic hemodynamics in advanced cirrhosis

2004-003238-32Phase 2Completed

Sponsor
Department of Clinical Pharmacology
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of pioglitazone in Cirrhosis, sponsored by Department of Clinical Pharmacology. Primary endpoint: Hepatic venous pressure gradient (HPVG) before and after test meal. Started Nov 2004; status: completed.

02

Drugs

pioglitazone
03

Conditions

Cirrhosis

Beyond the preview

Go deeper on 2004-003238-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003238-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call